Valarie Higgins, Managing Director & President of Almac Clinical Technologies at Almac Group will be speaking at the British American Business Council of Greater Philadelphia‘s June 7th event:
–> The Future of Immune Health – A Fireside Chat Featuring Global Health Sciences Leaders Almac Group & Penn Medicine
Award-winning professional coach Kathleen Fanning, PCC, would love to connect with fellow members to get to know you and to build professional connections and referrals.
Named ICF Ireland’s Career Coach of the Year, Kathleen’s 25 years of experience in Business, Higher Education and Public sector have led her around the world, but she is now happily based in Tipperary. She is offering complimentary 30 minutes to ‘pause and reflect’ on your goals and intentions for the rest of 2022.
Imvax to sponsor & participate in Taking on Cancer: How the Philadelphia region is leading the fight against the deadly disease
The Greater Philadelphia has thousands of people — doctors, scientists, business executives and more — who go to work every day with a mission to make life better for those touched by cancer. The Philadelphia Business Journal has assembled nine of them to discuss the region’s cancer ecosystem.
Acumen Analytics Launches ‘Life Sphere’ A New Podcast Dedicated to the People in Life Sciences.
The podcast features experts and advocates discussing trends, tools, careers and all components of the Life Sciences industry.
The first episodes of season one will be available May 3. New episodes will be released on Tuesdays. To learn more about Life Sphere, check the Acumen website for more details as they become available https://acumenanalytics.com/news/
Irish Chamber Board Member, Eric Karas, is a recognized commercial leader in the biopharmaceutical industry with more than 25 years of sales, marketing, market access, and strategic planning experience across multiple specialty product launches.
Mr. Karas was recently appointed Chief Commercial Officer with ARS Pharma. Prior he was Vice President & General Manager of Commercial, North America at Emergent BioSolutions. He also led commercial initiatives for NARCAN® Nasal Spray at Adapt Pharmaceutical, which was acquired by Emergent in 2018. Before Adapt Pharmaceutical, Mr. Karas was credited with being at the forefront of Auxilium Pharmaceuticals’ growth during his 8-year tenure and overseeing all global commercial objectives related to its urology portfolio. He also led the launch readiness planning and go-to-market strategy for the launch of XIAFLEX® for Peyronie’s disease. Auxilium was acquired in 2015 by Endo Pharmaceuticals.
Mr. Karas also has held cross-functional roles in government affairs, public relations, patient advocacy, and sales leadership roles at Astellas, Bristol-Myers Squibb, and Merck. Industry associations have also recognized him for numerous disease awareness and branded campaigns targeting HCPs and consumers.
Mr. Karas received his MBA in Integrated Management from Michigan State University, Broad School of Management, and a Bachelor of Science in Accounting from Rutgers University.
Thank you to our members who continue to support the Chamber through their membership, you make our mission possible!
Renewing members in February (to date):
Large Corporate Members:
• Dailey LLP, Jeffery A. Dailey
Mid-Size Firm Members:
• Galera Therapeutics, Mel Sorensen
• The Irish Memorial, John Donovan & Bob Gessler
• Francis P. McGee, The McGee Group LLC
• Michael Shanahan, Alvarez and Marsal
• Michael O’Rourke, Dortek
• Dianne P. Manges, CFA, Truist Foundations & Endowments Specialty Practice
• Michael Kiernan, Earp Cohn PC
• Roddy Flynn, Office of Congresswoman Mary Gay Scanlon (PA-05)
• Michael Maloney, CBRE